BCL9 and colonic neoplasm: Indeed, a BCL9 peptide mimetic was shown to disrupt native β-catenin/BCL9 complexes and lead to reduced WNT target gene expression in colon cancer cell lines and inhibited tumour growth in a colon cancer xenograft model [84] Other small molecule inhibitors of BCL9 have also been discovered.